The efficacy of diacerein in hand osteoarthritis: a double-blind, randomized, placebo-controlled study.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical Therapeutics

• Publication date

  2013-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clinthera.2013.02.009PMID 23474153
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diacerein for osteoarthritis.

  2014cited by this paper
• A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis.

  2012cited by this paper
• American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee

  2012cited by this paper
• Role of proinflammatory cytokines in the pathophysiology of osteoarthritis

  2011cited by this paper
• Assessing health-related quality of life in hand osteoarthritis: a literature review

  2011cited by this paper
• Cross-cultural adaptation, validation, and responsiveness of the Korean version of the AUSCAN Osteoarthritis Index

  2011cited by this paper
• Allelic variants of IL1R1 gene associate with severe hand osteoarthritis

  2010cited by this paper
• Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials.

  2010cited by this paper
• High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study.

  2010cited by this paper
• Diclofenac Sodium Gel in Patients with Primary Hand Osteoarthritis: A Randomized, Double-blind, Placebo-controlled Trial

  2009cited by this paper
• Efficacy and safety of diacerein in early knee osteoarthritis: a randomized placebo-controlled trial

  2009cited by this paper
• Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodelling

  2008cited by this paper
• EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT

  2008cited by this paper
• Efficacy and safety of a novel synergistic drug candidate, CRx-102, in hand osteoarthritis

  2007cited by this paper
• Health-related quality of life in women with symptomatic hand osteoarthritis: a comparison with rheumatoid arthritis patients, healthy controls, and normative data.

  2007cited by this paper
• Short‐term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta‐analysis of randomised placebo‐controlled trials

  2007cited by this paper
• Choosing between NSAID and arnica for topical treatment of hand osteoarthritis in a randomised, double-blind study

  2007cited by this paper
• The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled study.

  2007cited by this paper
• Clinical update: treating osteoarthritis.

  2007cited by this paper
• The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period.

  2007cited by this paper
• Diacerein for osteoarthritis.

  2006cited by this paper
• Design and conduct of clinical trials in patients with osteoarthritis of the hand: recommendations from a task force of the Osteoarthritis Research Society International.

  2006cited by this paper
• A meta-analysis of controlled clinical studies with diacerein in the treatment of osteoarthritis.

  2006cited by this paper
• Hand osteoarthritis.

  2005cited by this paper
• Prevalence and determinants of one month hand pain and hand related disability in the elderly (Rotterdam study)

  2004cited by this paper
• Association of erosive hand osteoarthritis with a single nucleotide polymorphism on the gene encoding interleukin-1 beta.

  2003cited by this paper
• SACRAH: a score for assessment and quantification of chronic rheumatic affections of the hands.

  2003cited by this paper
• Clinimetric properties of the AUSCAN Osteoarthritis Hand Index: an evaluation of reliability, validity and responsiveness.

  2002cited by this paper
• Systems to Assess the Progression of Finger Joint Osteoarthritis and the Effects of Disease Modifying Osteoarthritis Drugs

  2002cited by this paper
• Dimensionality and clinical importance of pain and disability in hand osteoarthritis: Development of the Australian/Canadian (AUSCAN) Osteoarthritis Hand Index.

  2002cited by this paper
• The effects of orally administered diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis.

  2001cited by this paper
• Diacerein suppresses the increase in plasma nitric oxide in rat adjuvant-induced arthritis.

  2001cited by this paper
• Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip.

  2001cited by this paper
• Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group.

  2000cited by this paper
• Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis.

  1999cited by this paper
• Diacerhein and rhein reduce the interleukin 1beta stimulated inducible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes.

  1998cited by this paper
• In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes.

  1998cited by this paper
• The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand.

  1990cited by this paper

• Systematic review and network meta-analysis on the efficacy and safety of parmacotherapy for hand osteoarthritis

  2024cites this paper
• Report of similar placebo response in one internet versus onsite randomised controlled trials from the literature

  2024cites this paper
• Diacerein versus non-steroidal anti-inflammatory drugs in the treatment of knee osteoarthritis: a meta-analysis

  2023cites this paper
• Systematic Review of Non-surgical Therapies for Osteoarthritis of the Hand: An Update

  2023cites this paper
• Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach

  2022cites this paper
• Osteoarthritis of the joints of the hands. Review of clinical recommendations

  2022cites this paper
• Predictors of a placebo response in patients with hand osteoarthritis: post-hoc analysis of two randomized controlled trials

  2021cites this paper
• Comparative Efficacy and Safety of Diacerein in Patients with Knee Osteoarthritis: A Pilot Study in Patients with A

  2021cites this paper
• Choice of control group treatments in hand osteoarthritis trials: A systematic review and meta-analysis.

  2021cites this paper
• Experts document about an adequate utilization of SYSADOAs in controversial clinical situations.

  2021cites this paper
• Experts Document About an Adequate Utilization of SYSADOAs in Controversial Clinical Situations.

  2020cites this paper
• Documento de expertos sobre el uso apropiado de los SYSADOA en situaciones clínicas controvertidas

  2020cites this paper
• Chemokine and Cytokine Profiles in Patients with Hand Osteoarthritis

  2020cites this paper
• Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis

  2019cites this paper
• Efficacy and safety of non-pharmacological, pharmacological and surgical treatment for hand osteoarthritis: a systematic literature review informing the 2018 update of the EULAR recommendations for the management of hand osteoarthritis

  2018cites this paper
• Investigational drugs for the treatment of osteoarthritis, an update on recent developments

  2018cites this paper
• Serum Concentrations and Elimination Rates of Direct-Acting Oral Anticoagulants (DOACs) in Older Hip Fracture Patients Hospitalized for Surgery: A Pilot Study

  2018cites this paper
• Inhaled steroids with and without regular salmeterol for asthma: serious adverse events.

  2018cites this paper
• Efficacy of Hydroxychloroquine in Hand Osteoarthritis: A Randomized, Double‐Blind, Placebo‐Controlled Trial

  2018cites this paper
• Comments on Alegría and Irarrázaval (2017): Is diacerein an alternative for the treatment of osteoarthritis?

  2018cites this paper
• Diacerein reduces joint damage, pain behavior and inhibits transient receptor potential vanilloid 1, matrix metalloproteinase and glial cells in rat spinal cord

  2017cites this paper
• Are We Using Slow-Acting Symptomatic Chondroprotective Drugs Conscious Enough?

  2017cites this paper
• Systematic review of non-surgical therapies for osteoarthritis of the hand: an update.

  2017cites this paper
• Developing anti-inflammatory therapeutics for patients with osteoarthritis

  2016cites this paper
• Risk factors and outcome measures in hand and knee osteoarthritis

  2016cites this paper
• Efficacy and Tolerability of GCSB-5 for Hand Osteoarthritis: A Randomized, Controlled Trial.

  2016cites this paper
• Instruments Measuring Pain, Physical Function, or Patient’s Global Assessment in Hand Osteoarthritis: A Systematic Literature Search

  2015cites this paper
• Hand Osteoarthritis: An Update on Therapy

  2015cites this paper
• Evidencias y recomendaciones actuales sobre el tratamiento de la artrosis

  2015cites this paper
• Targets, models and challenges in osteoarthritis research

  2015cites this paper
• Diacerein for osteoarthritis.

  2014cites this paper
• Nutraceuticals and chondroprotective agents for the treatment of osteoarthritis: a narrative review. A controversial resource in the treatment of osteoarthritis

  2014cites this paper
• Emerging pathways and promising agents with possible disease modifying effect in osteoarthritis treatment.

  2014cites this paper
• Involvement of the endocannabinoid system in osteoarthritis pain

  2014cites this paper
• Chapter 9 - Anti-inflammatory and antipyretic analgesics and drugs used in gout

  2014cites this paper
• Pharmacologic treatment of hand-, knee- and hip-osteoarthritis

  2013cites this paper
• Pain therapeutics in older adults.

  2013cites this paper